Study guide
5.2 Percentage Strengths, Ratio Strengths, and Liquid Concentrations (mg/mL)
PTCB Technician Product Verification TPV
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Introduction & Tech-Check-Tech Verification Fundamentals
1.1 About the PTCB TPV Certificate Exam 1.2 Tech-Check-Tech (TCT) Scope, Regulations, and Quality Assurance 1.3 Systematic Verification Protocol & Visual Inspection Steps
2 Chapter 2: Drug Name Verification & Brand/Generic Identification
2.1 Brand vs Generic Mapping, USAN Stems, and Orange Book Therapeutic Equivalence 2.2 Salt Forms and Active Ingredient Verification 2.3 Manufacturer-Specific Identification, Visual Cues, and Color Codes
3 Chapter 3: Auxiliary Labels, REMS & Controlled Substances
3.1 Auxiliary Warning Labels and Mandatory Patient Counseling Triggers 3.2 REMS Programs and Restricted Distribution Medications 3.3 Controlled Substance Scheduling, Refill Restrictions, and C-II Exact Counts
4 Chapter 4: Dosage Forms, Release Mechanisms & Administration Routes
4.1 Modified-Release Formulations (ER, XL, SR, DR, CR) and "Do Not Crush" Rules 4.2 Route of Administration Verification: Ophthalmic vs Otic, Oral vs Topical vs Transdermal 4.3 Specialized Delivery Systems: Inhalers (MDI/DPI), ODTs, Solutions vs Suspensions
5 Chapter 5: Strength Verification & Pharmaceutical Calculations
5.1 Unit Conversions (mcg, mg, g) and Preventing Leading/Trailing Zero Errors 5.2 Percentage Strengths, Ratio Strengths, and Liquid Concentrations (mg/mL) 5.3 Electrolyte Equivalents (mEq vs mg) and Combination Product Strength Verification
6 Chapter 6: High-Alert Medications & Safety Protocols
6.1 ISMP High-Alert Medications and Independent Double-Check Protocols 6.2 Insulin Formulations, Concentrations (U-100, U-500, U-200, U-300), and Pen/Vial Math 6.3 Concentrated Electrolytes, Opioids, Neuromuscular Blockers, and Oral Methotrexate
7 Chapter 7: Look-Alike / Sound-Alike (LASA) Medications
7.1 FDA and ISMP Tall-Man Lettering Principles 7.2 High-Risk Community/Ambulatory LASA Pairs 7.3 High-Risk Institutional/Hospital LASA Pairs & Packaging Traps
8 Chapter 8: Packaging, Expiration, Storage & Special Handling
8.1 Expiration Date Interpretation and Multi-Dose Vial Beyond-Use Dating (BUD) 8.2 Packaging Integrity, Moisture/Light Sensitivity, and FDA Recall Classes 8.3 Temperature Storage Ranges and Vaccine Cold Chain Integrity 8.4 USP <800> Hazardous Drug Identification and Handling Precautions
9 Chapter 9: NDC Conversion, Repackaging & Final Dispensing Checks
9.1 NDC 10-Digit to 11-Digit Conversion (5-4-2 Standardization) 9.2 Unit-Dose Repackaging Standards and USP <795> BUD Guidelines 9.3 Days Supply Calculations, Package Size Verification, and Final Label Matching
5.2 Percentage Strengths, Ratio Strengths, and Liquid Concentrations (mg/mL)
Key Takeaways Explain This Topic AI
Weight-in-Volume (w/v %) expresses grams of active solute per 100 mL of solution; applying the 'Rule of 10' shortcut (multiplying the percentage number by 10) instantly provides the concentration in mg/mL (e.g., 0.9% NaCl = 9 mg/mL; 5% Dextrose = 50 mg/mL; 2% Lidocaine = 20 mg/mL).
Weight-in-Weight (w/w %) expresses grams of active drug per 100 grams of semi-solid product (e.g., Hydrocortisone 1% cream contains 1 g of drug in 100 g, or 300 mg in a 30 g tube).
Ratio strength (1:N) indicates 1 gram of solute in N mL of liquid; Epinephrine 1:1,000 equals 1 mg/mL (administered Intramuscularly for anaphylaxis), whereas Epinephrine 1:10,000 equals 0.1 mg/mL (administered Intravenously for cardiac arrest).
Administering Epinephrine 1:1,000 intravenously instead of 1:10,000 delivers a fatal 10-fold overdose resulting in severe hypertension, ventricular arrhythmias, and myocardial infarction.
Verifying liquid dispensing requires calculating dose volume: Volume (mL) = Dose (mg) / Concentration (mg/mL), and validating total dispensed volume against days supply and calibrated measuring devices.
Last updated: August 2026
Percentage Strengths, Ratio Strengths, and Liquid Concentrations
Core Verification Rule: In liquid and semi-solid dosage form verification, the technician must independently convert percentage strengths, ratio strengths, and metric concentration expressions into exact milligram-per-milliliter ( m g / m L mg/mL m g / m L ) or milligram-per-gram ( m g / g mg/g m g / g ) values to verify that the patient receives the exact prescribed therapeutic dose.
Concentrations in pharmacy practice are expressed in various formats depending on the physical state of the drug (solute) and the base or solvent (vehicle). Verifying technicians must fluidly navigate between percentage strengths, ratio strengths, and standard metric concentrations to prevent severe compounding and dispensing miscalculations.
1. Percentage Strength Expressions
A percentage strength represents parts of active ingredient per 100 parts of total mixture. In pharmaceutical calculations, three distinct percentage strength expressions exist based on the physical state of the components: ┌────────────────────────────────────────────────────────────────────────┐
- │ PERCENTAGE STRENGTH TYPES │
- ├────────────────────────────────────────────────────────────────────────┤
- │ 1. Weight-in-Volume (w/v %): Grams of solute in 100 mL of solution │
- │ • Used for IV fluids, oral solutions, ophthalmic drops │
- │ • Example: 0.9% NaCl = 0.9 g NaCl per 100 mL of solution │
- │ │
- │ 2. Weight-in-Weight (w/w %): Grams of solute in 100 g of product │
- │ • Used for ointments, creams, gels, bulk compounding powders │
- │ • Example: 1% Hydrocortisone = 1 g active drug per 100 g cream │
- │ │
- │ 3. Volume-in-Volume (v/v %): Milliliters of solute in 100 mL liquid │
- │ • Used for liquid solutes dissolved in liquid solvents │
- │ • Example: 70% Isopropyl Alcohol = 70 mL alcohol in 100 mL solution│
- └────────────────────────────────────────────────────────────────────────┘
- The 'Rule of 10' Verification Shortcut for w/v %
For any Weight-in-Volume ( w / v w/v w / v ) percentage strength, multiplying the percentage number by 10 instantly yields the exact concentration in milligrams per milliliter ( m g / m L mg/mL m g / m L ) : Concentration (mg/mL) = Percentage Value (%) × 10 \text{Concentration (mg/mL)} = \text{Percentage Value (\%)} \times 10 Concentration (mg/mL) = Percentage Value (%) × 10
Normal Saline ( 0.9 % NaCl 0.9\% \text{ NaCl} 0.9% NaCl ): 0.9 × 10 = 9 mg/mL 0.9 \times 10 = \mathbf{9 \text{ mg/mL}} 0.9 × 10 = 9 mg/mL ( 0.9 g / 100 mL = 900 mg / 100 mL = 9 mg/mL 0.9 \text{ g}/100 \text{ mL} = 900 \text{ mg}/100 \text{ mL} = 9 \text{ mg/mL} 0.9 g /100 mL = 900 mg /100 mL = 9 mg/mL )
Half-Normal Saline ( 0.45 % NaCl 0.45\% \text{ NaCl} 0.45% NaCl ): 0.45 × 10 = 4.5 mg/mL 0.45 \times 10 = \mathbf{4.5 \text{ mg/mL}} 0.45 × 10 = 4.5 mg/mL
Hypertonic Saline ( 3 % NaCl 3\% \text{ NaCl} 3% NaCl ): 3.0 × 10 = 30 mg/mL 3.0 \times 10 = \mathbf{30 \text{ mg/mL}} 3.0 × 10 = 30 mg/mL
Dextrose 5% in Water (D5W): 5.0 × 10 = 50 mg/mL 5.0 \times 10 = \mathbf{50 \text{ mg/mL}} 5.0 × 10 = 50 mg/mL ( 5 g / 100 mL = 5 , 000 mg / 100 mL = 50 mg/mL 5 \text{ g}/100 \text{ mL} = 5,000 \text{ mg}/100 \text{ mL} = 50 \text{ mg/mL} 5 g /100 mL = 5 , 000 mg /100 mL = 50 mg/mL )
Dextrose 10% in Water (D10W): 10.0 × 10 = 100 mg/mL 10.0 \times 10 = \mathbf{100 \text{ mg/mL}} 10.0 × 10 = 100 mg/mL
Dextrose 50% in Water (D50W): 50.0 × 10 = 500 mg/mL 50.0 \times 10 = \mathbf{500 \text{ mg/mL}} 50.0 × 10 = 500 mg/mL
- Lidocaine 1% Injection: 1.0 × 10 = 10 mg/mL 1.0 \times 10 = \mathbf{10 \text{ mg/mL}} 1.0 × 10 = 10 mg/mL
- Lidocaine 2% Injection: 2.0 × 10 = 20 mg/mL 2.0 \times 10 = \mathbf{20 \text{ mg/mL}} 2.0 × 10 = 20 mg/mL
- Common Pharmaceutical Percentage Solutions & Solute Contents
Solution Description Percentage ( w / v w/v w / v ) Concentration ( m g / m L mg/mL m g / m L ) Solute Content per 500 mL 500 \text{ mL} 500 mL Bag Solute Content per 1 , 000 mL 1,000 \text{ mL} 1 , 000 mL ( 1 L 1 \text{ L} 1 L ) Bag
0.9 % Sodium Chloride (NS) 0.9\% \text{ Sodium Chloride (NS)} 0.9% Sodium Chloride (NS) 0.9 % 0.9\% 0.9% 9 mg/mL 9 \text{ mg/mL} 9 mg/mL 4.5 g 4.5 \text{ g} 4.5 g ( 4 , 500 mg 4,500 \text{ mg} 4 , 500 mg ) 9 g 9 \text{ g} 9 g ( 9 , 000 mg 9,000 \text{ mg} 9 , 000 mg )
0.45 % Sodium Chloride (1/2 NS) 0.45\% \text{ Sodium Chloride (1/2 NS)} 0.45% Sodium Chloride (1/2 NS) 0.45 % 0.45\% 0.45% 4.5 mg/mL 4.5 \text{ mg/mL} 4.5 mg/mL 2.25 g 2.25 \text{ g} 2.25 g ( 2 , 250 mg 2,250 \text{ mg} 2 , 250 mg ) 4.5 g 4.5 \text{ g} 4.5 g ( 4 , 500 mg 4,500 \text{ mg} 4 , 500 mg )
3 % Sodium Chloride (Hypertonic) 3\% \text{ Sodium Chloride (Hypertonic)} 3% Sodium Chloride (Hypertonic) 3.0 % 3.0\% 3.0% 30 mg/mL 30 \text{ mg/mL} 30 mg/mL 15 g 15 \text{ g} 15 g ( 15 , 000 mg 15,000 \text{ mg} 15 , 000 mg ) 30 g 30 \text{ g} 30 g ( 30 , 000 mg 30,000 \text{ mg} 30 , 000 mg )
5 % Dextrose in Water (D5W) 5\% \text{ Dextrose in Water (D5W)} 5% Dextrose in Water (D5W) 5.0 % 5.0\% 5.0% 50 mg/mL 50 \text{ mg/mL} 50 mg/mL 25 g 25 \text{ g} 25 g ( 25 , 000 mg 25,000 \text{ mg} 25 , 000 mg ) 50 g 50 \text{ g} 50 g ( 50 , 000 mg 50,000 \text{ mg} 50 , 000 mg )
10 % Dextrose in Water (D10W) 10\% \text{ Dextrose in Water (D10W)} 10% Dextrose in Water (D10W) 10.0 % 10.0\% 10.0% 100 mg/mL 100 \text{ mg/mL} 100 mg/mL 50 g 50 \text{ g} 50 g ( 50 , 000 mg 50,000 \text{ mg} 50 , 000 mg ) 100 g 100 \text{ g} 100 g ( 100 , 000 mg 100,000 \text{ mg} 100 , 000 mg )
50 % Dextrose (D50W Vial) 50\% \text{ Dextrose (D50W Vial)} 50% Dextrose (D50W Vial) 50.0 % 50.0\% 50.0% 500 mg/mL 500 \text{ mg/mL} 500 mg/mL N/A ( 50 mL vial = 25 g 50 \text{ mL vial} = 25 \text{ g} 50 mL vial = 25 g ) N/A
Weight-in-Weight ( w / w w/w w / w ) Semi-Solid Verification
Topical preparations (ointments, creams, lotions) are expressed as w / w % w/w \% w / w % . To find the total mass of active pharmaceutical ingredient (API) in a commercial tube: Active Drug Mass (g) = Total Package Weight (g) × ( Percentage 100 ) \text{Active Drug Mass (g)} = \text{Total Package Weight (g)} \times \left( \frac{\text{Percentage}}{100} \right) Active Drug Mass (g) = Total Package Weight (g) × ( 100 Percentage )
Hydrocortisone 1% Cream in a 30 g Tube: 30 g × 0.01 = 0.3 g = 300 mg 30 \text{ g} \times 0.01 = 0.3 \text{ g} = \mathbf{300 \text{ mg}} 30 g × 0.01 = 0.3 g = 300 mg of pure hydrocortisone.
Hydrocortisone 2.5% Ointment in a 45 g Tube: 45 g × 0.025 = 1.125 g = 1 , 125 mg 45 \text{ g} \times 0.025 = 1.125 \text{ g} = \mathbf{1,125 \text{ mg}} 45 g × 0.025 = 1.125 g = 1 , 125 mg of pure hydrocortisone.
Triamcinolone Acetonide 0.1% Cream in an 80 g Tube: 80 g × 0.001 = 0.08 g = 80 mg 80 \text{ g} \times 0.001 = 0.08 \text{ g} = \mathbf{80 \text{ mg}} 80 g × 0.001 = 0.08 g = 80 mg of triamcinolone.
2. Ratio Strengths and the High-Alert Epinephrine Landmark
A ratio strength is expressed as 1 : N 1:N 1 : N , which defines 1 part of active drug in N N N total parts of solution or mixture .
For liquid solutions: 1 g 1 \text{ g} 1 g of active solute in N mL N \text{ mL} N mL of total solution .
For solid mixtures: 1 g 1 \text{ g} 1 g of active drug in N g N \text{ g} N g of total mixture .
Conversion Formulas for Ratio Strengths Percentage Strength (%) = 1 N × 100 \text{Percentage Strength (\%)} = \frac{1}{N} \times 100 Percentage Strength (%) = N 1 × 100 Concentration (mg/mL) = 1 , 000 mg N mL \text{Concentration (mg/mL)} = \frac{1,000 \text{ mg}}{N \text{ mL}} Concentration (mg/mL) = N mL 1 , 000 mg
Ratio Strength Fraction Percentage Strength ( w / v w/v w / v ) Concentration ( m g / m L mg/mL m g / m L ) Clinical Use Examples
1 : 100 1:100 1 : 100 1 / 100 1/100 1/100 1.0 % 1.0\% 1.0% 10 mg/mL 10 \text{ mg/mL} 10 mg/mL Concentrated antiseptics, topical solutions
1 : 1 , 000 1:1,000 1 : 1 , 000 1 / 1 , 000 1/1,000 1/1 , 000 0.1 % 0.1\% 0.1% 1 mg/mL 1 \text{ mg/mL} 1 mg/mL Epinephrine IM (anaphylaxis), topical vasoconstrictors
1 : 2 , 000 1:2,000 1 : 2 , 000 1 / 2 , 000 1/2,000 1/2 , 000 0.05 % 0.05\% 0.05% 0.5 mg/mL 0.5 \text{ mg/mL} 0.5 mg/mL Nitrofurazone topical solution
1 : 10 , 000 1:10,000 1 : 10 , 000 1 / 10 , 000 1/10,000 1/10 , 000 0.01 % 0.01\% 0.01% 0.1 mg/mL 0.1 \text{ mg/mL} 0.1 mg/mL Epinephrine IV / IO (cardiac arrest / ACLS code)
1 : 100 , 000 1:100,000 1 : 100 , 000 1 / 100 , 000 1/100,000 1/100 , 000 0.001 % 0.001\% 0.001% 0.01 mg/mL 0.01 \text{ mg/mL} 0.01 mg/mL Epinephrine with local anesthetics (e.g., Lidocaine with Epi)
Critical Safety Landmark: Epinephrine 1:1,000 vs. Epinephrine 1:10,000
One of the most critical high-alert safety distinctions on the PTCB TPV examination involves the dual concentrations and administration routes of Epinephrine (adrenaline). ┌────────────────────────────────────────────────────────────────────────┐
- │ THE EPINEPHRINE VERIFICATION MATRIX │
- ├────────────────────────────────────────────────────────────────────────┤
- │ EPINEPHRINE 1:1,000 (1 mg/mL) │ EPINEPHRINE 1:10,000 (0.1 mg/mL)│
- ├───────────────────────────────────────┼────────────────────────────────┤
- │ • Concentration: 1 mg per 1 mL │ • Concentration: 0.1 mg per 1 mL│
- │ • Route: INTRAMUSCULAR (IM) or SC │ • Route: INTRAVENOUS (IV) / IO │
- │ • Indication: ACUTE ANAPHYLAXIS │ • Indication: CARDIAC ARREST │
- │ • Delivery: Anterolateral thigh │ • Delivery: Central/peripheral │
- │ • Standard Adult Dose: 0.3 mg (0.3 mL)│ • Standard Adult Dose: 1 mg │
- │ • Standard Peds Dose: 0.15 mg(0.15 mL)│ (10 mL prefilled syringe) │
- │ • Package: Ampule / Auto-injector │ • Package: Bristoject Syringe │
- └───────────────────────────────────────┴────────────────────────────────┘
Caution
Fatal Error Hazard: Epinephrine 1:1,000 is TEN TIMES (10x) more concentrated than Epinephrine 1:10,000. If Epinephrine 1:1,000 (1 mg/mL) is inadvertently administered intravenously instead of 1:10,000, it causes immediate severe coronary vasoconstriction, malignant ventricular fibrillation, hypertensive crisis, cerebral hemorrhage, and death.
Regulatory Note: To prevent fatal ratio errors, the USP and FDA mandated that manufacturer packaging display metric concentrations prominently (e.g., 1 mg/mL and 0.1 mg/mL rather than only ratio expressions). However, verifying technicians must be proficient in checking both historical ratio orders and modern metric labels.
3. Liquid Dosing Calculations & Days Supply Verification
Verifying commercial liquid solutions and reconstituted suspensions requires checking three interconnected variables:
- Dose Volume (mL per administration)
- Daily Volume (mL consumed per 24 hours)
- Total Quantity Dispensed & Days Supply Alignment
The Core Dosing Formula Volume per Dose (mL) = Dose Ordered (mg) Concentration of Product (mg/mL) \text{Volume per Dose (mL)} = \frac{\text{Dose Ordered (mg)}}{\text{Concentration of Product (mg/mL)}} Volume per Dose (mL) = Concentration of Product (mg/mL) Dose Ordered (mg) Daily Volume (mL/day) = Volume per Dose (mL) × Frequency (doses/day) \text{Daily Volume (mL/day)} = \text{Volume per Dose (mL)} \times \text{Frequency (doses/day)} Daily Volume (mL/day) = Volume per Dose (mL) × Frequency (doses/day) Days Supply = Total Volume Dispensed (mL) Daily Volume (mL/day) \text{Days Supply} = \frac{\text{Total Volume Dispensed (mL)}}{\text{Daily Volume (mL/day)}} Days Supply = Daily Volume (mL/day) Total Volume Dispensed (mL)
Step-by-Step Verification Case Study: Pediatric Suspension
Prescription Hardcopy:
- Rx: Amoxicillin Oral Suspension
- Sig: Give 400 mg 400 \text{ mg} 400 mg PO BID × 10 days \times 10 \text{ days} × 10 days
Product Selected by Filling Technician:
Bottle: Amoxicillin 400 mg / 5 mL 400 \text{ mg}/5 \text{ mL} 400 mg /5 mL powder for oral suspension (Total reconstituted volume: 100 mL 100 \text{ mL} 100 mL )
Verification Arithmetic:
Concentration: 400 mg / 5 mL = 80 mg/mL 400 \text{ mg} / 5 \text{ mL} = 80 \text{ mg/mL} 400 mg /5 mL = 80 mg/mL .
Single Dose Volume: 400 mg ÷ 80 mg/mL = 5 mL 400 \text{ mg} \div 80 \text{ mg/mL} = \mathbf{5 \text{ mL}} 400 mg ÷ 80 mg/mL = 5 mL (or 1 teaspoonful).
Daily Volume: 5 mL × 2 doses/day = 10 mL/day 5 \text{ mL} \times 2 \text{ doses/day} = \mathbf{10 \text{ mL/day}} 5 mL × 2 doses/day = 10 mL/day .
Total Volume Needed for 10 Days: 10 mL/day × 10 days = 100 mL 10 \text{ mL/day} \times 10 \text{ days} = \mathbf{100 \text{ mL}} 10 mL/day × 10 days = 100 mL .
Package Size Match: The 100 mL 100 \text{ mL} 100 mL bottle provides exactly a 10-day supply ( 100 mL ÷ 10 mL/day = 10 days 100 \text{ mL} \div 10 \text{ mL/day} = 10 \text{ days} 100 mL ÷ 10 mL/day = 10 days ). Verification PASS.
Common Liquid Verification Pitfalls
Mismatched Concentration Selection: A patient is prescribed Amoxicillin 250 mg / 5 mL 250 \text{ mg}/5 \text{ mL} 250 mg /5 mL with directions to take 5 mL 5 \text{ mL} 5 mL ( 250 mg 250 \text{ mg} 250 mg ). If the technician verifies an Amoxicillin 400 mg / 5 mL 400 \text{ mg}/5 \text{ mL} 400 mg /5 mL bottle with directions reading "Take 5 mL" , the patient receives 400 mg 400 \text{ mg} 400 mg per dose (a 60% overdose ).
Shortfall Due to Container Sizes: An order requires 15 mL 15 \text{ mL} 15 mL daily for 14 days ( 210 mL 210 \text{ mL} 210 mL total). Dispensing a single 150 mL 150 \text{ mL} 150 mL manufacturer bottle leaves the patient with only a 10-day supply, causing premature therapy cessation and antibiotic resistance. The technician must verify that two bottles ( 150 mL + 100 mL = 250 mL 150 \text{ mL} + 100 \text{ mL} = 250 \text{ mL} 150 mL + 100 mL = 250 mL ) are dispensed to fulfill the full 14-day course.